spacer
home > pmps > spring 2017 > open and close
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Open and Close

For packaging to be child-resistant, it must be difficult for a child under the age of four years and four months (52 months) to open or gain access to the contents in a reasonable period – but not challenging for an adult up to 70 years old to use properly. This is the generally accepted definition, and is used in international and European standards as well as the Code of Federal Regulations (CFR) in the US (it is worth noting at this point that child-resistant packaging is not ‘child-proof’).

Child-resistant reclosable packs were first introduced in the UK in the mid- 1970s as an American import and have achieved increasing acceptance in the UK and other EU member states over the past 40 years. In Britain, non-reclosable child-resistant packs were slow to emerge and were only standardised in 2001. As well as being subject to international, European and American standards, the use of child-resistant packs for certain products has been set out in various regulations, including the Human Medicines Regulations 2012 and the globally harmonised system of classification and labelling chemicals, which came into full force in 2015.

Since its introduction, this type of packaging has been improved and made more effective, not only in levels of resistance to opening by children but in its ease-of-use by adults. In addition, increasing and ongoing efforts have been made to create more lightweight packaging across the board.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Stephen Wilkins was appointed Chief Executive Officer of the Child-Safe Packaging Group upon its formation in 1995 and has driven its activities since then. In addition, he is Director of Davies Development and Testing and sits on a number of BSI and ISO committees concerned with developing standards for packaging. Stephen attended the University of Durham Business School, UK, where he obtained a Master’s degree in Business Administration.
spacer
Stephen Wilkins
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Synpromics expands facilities to meet demand for revolutionary gene control technology

Edinburgh, UK, 11th September 2017 - Synpromics Ltd, the leader in gene control and synthetic promoter development, today moves to new world-class facilities at the Roslin Innovation Centre. Synpromics is expanding to meet increasing global demand for its cutting-edge gene control technology, and is the first company to move into the new custom-built centre based at the University of Edinburgh’s Easter Bush Campus.
More info >>

White Papers

Wrap Around Label - A Lot of Content in a Small Space

Faubel & Co. Nachfolger GmbH

One of the world’s largest contract research organizations for the planning and conducting of clinical trials was faced with the challenge of accommodating many different national languages on an inhaler. The inhaler was then to be distributed in 47 countries. Due to the impressive quality and reliable collaboration, the organization commissioned Faubel with finding the optimal labeling solution for the inhaler.
More info >>

 
Industry Events

Outsourcing in clinical Trial Medical Devices Europe 2018

7-8 February 2018, Munich, Germany

Outsourcing in Clinical Trials: Medical Devices Europe has now reached its fifth birthday. This event is focused on Medical devices. At this event you will learn about the new regulations, which were released this may, regarding medical devices in more detail, from speakers who are the heads in their respective fields.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement